Cost of chiropractic versus medical management of adults with spine-related musculoskeletal pain: a systematic review.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-03-06 DOI:10.1186/s12998-024-00533-4
Ronald Farabaugh, Cheryl Hawk, Dave Taylor, Clinton Daniels, Claire Noll, Mike Schneider, John McGowan, Wayne Whalen, Ron Wilcox, Richard Sarnat, Leonard Suiter, James Whedon
{"title":"Cost of chiropractic versus medical management of adults with spine-related musculoskeletal pain: a systematic review.","authors":"Ronald Farabaugh, Cheryl Hawk, Dave Taylor, Clinton Daniels, Claire Noll, Mike Schneider, John McGowan, Wayne Whalen, Ron Wilcox, Richard Sarnat, Leonard Suiter, James Whedon","doi":"10.1186/s12998-024-00533-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The cost of spine-related pain in the United States is estimated at $134.5 billion. Spinal pain patients have multiple options when choosing healthcare providers, resulting in variable costs. Escalation of costs occurs when downstream costs are added to episode costs of care. The purpose of this review was to compare costs of chiropractic and medical management of patients with spine-related pain.</p><p><strong>Methods: </strong>A Medline search was conducted from inception through October 31, 2022, for cost data on U.S. adults treated for spine-related pain. The search included economic studies, randomized controlled trials and observational studies. All studies were independently evaluated for quality and risk of bias by 3 investigators and data extraction was performed by 3 investigators.</p><p><strong>Results: </strong>The literature search found 2256 citations, of which 93 full-text articles were screened for eligibility. Forty-four studies were included in the review, including 26 cohort studies, 17 cost studies and 1 randomized controlled trial. All included studies were rated as high or acceptable quality. Spinal pain patients who consulted chiropractors as first providers needed fewer opioid prescriptions, surgeries, hospitalizations, emergency department visits, specialist referrals and injection procedures.</p><p><strong>Conclusion: </strong>Patients with spine-related musculoskeletal pain who consulted a chiropractor as their initial provider incurred substantially decreased downstream healthcare services and associated costs, resulting in lower overall healthcare costs compared with medical management. The included studies were limited to mostly retrospective cohorts of large databases. Given the consistency of outcomes reported, further investigation with higher-level designs is warranted.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918856/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12998-024-00533-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The cost of spine-related pain in the United States is estimated at $134.5 billion. Spinal pain patients have multiple options when choosing healthcare providers, resulting in variable costs. Escalation of costs occurs when downstream costs are added to episode costs of care. The purpose of this review was to compare costs of chiropractic and medical management of patients with spine-related pain.

Methods: A Medline search was conducted from inception through October 31, 2022, for cost data on U.S. adults treated for spine-related pain. The search included economic studies, randomized controlled trials and observational studies. All studies were independently evaluated for quality and risk of bias by 3 investigators and data extraction was performed by 3 investigators.

Results: The literature search found 2256 citations, of which 93 full-text articles were screened for eligibility. Forty-four studies were included in the review, including 26 cohort studies, 17 cost studies and 1 randomized controlled trial. All included studies were rated as high or acceptable quality. Spinal pain patients who consulted chiropractors as first providers needed fewer opioid prescriptions, surgeries, hospitalizations, emergency department visits, specialist referrals and injection procedures.

Conclusion: Patients with spine-related musculoskeletal pain who consulted a chiropractor as their initial provider incurred substantially decreased downstream healthcare services and associated costs, resulting in lower overall healthcare costs compared with medical management. The included studies were limited to mostly retrospective cohorts of large databases. Given the consistency of outcomes reported, further investigation with higher-level designs is warranted.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脊柱相关肌肉骨骼疼痛成人患者脊骨神经治疗与药物治疗的成本对比:系统综述。
背景:在美国,脊柱相关疼痛的费用估计为 1,345 亿美元。脊柱疼痛患者在选择医疗服务提供者时有多种选择,从而导致成本可变。当下游成本被添加到一连串的护理成本中时,就会出现成本上升。本综述旨在比较脊柱相关疼痛患者脊骨神经治疗和药物治疗的成本:方法:对美国成人脊柱相关疼痛治疗的成本数据进行了 Medline 搜索,搜索时间从开始到 2022 年 10 月 31 日。检索包括经济研究、随机对照试验和观察性研究。所有研究的质量和偏倚风险均由 3 名调查人员独立评估,数据提取由 3 名调查人员完成:结果:文献检索发现了 2256 篇引文,其中 93 篇全文通过了资格筛选。综述共纳入 44 项研究,包括 26 项队列研究、17 项成本研究和 1 项随机对照试验。所有纳入的研究均被评为高质量或可接受质量。将脊骨神经科医生作为首诊医生的脊柱疼痛患者所需的阿片类药物处方、手术、住院、急诊就诊、专家转诊和注射程序均较少:结论:脊柱相关肌肉骨骼疼痛患者在首次就诊时向脊骨神经科医生咨询,可大幅减少下游医疗服务及相关费用,从而降低总体医疗费用。所纳入的研究大多局限于大型数据库中的回顾性队列。鉴于报告结果的一致性,有必要采用更高级别的设计进行进一步调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊最新文献
A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension. Advancing Patient Education in Idiopathic Intracranial Hypertension: The Promise of Large Language Models. Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments. Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey. Association Between LACE+ Index Risk Category and 90-Day Mortality After Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1